Nicole Stefańska, Joanna Wieczfinska, R. Pawliczak
Natural medicine, although it has been used for centuries, has only recently gained increasing interest and is treated as a remedy for all ailments. It is very often abused due to a lack of sufficient knowledge about potential adverse reactions and possible interactions between plant preparations and particular drugs. Moreover, traditional medicine used for a long period of time without restriction can lead to permanent damage to health and even death. This paper outlines the dangers of harmful effects of plant preparations when used inappropriately and when co-interacting substances are combined.
{"title":"The harmful effects of plant preparations","authors":"Nicole Stefańska, Joanna Wieczfinska, R. Pawliczak","doi":"10.5114/pja.2023.129091","DOIUrl":"https://doi.org/10.5114/pja.2023.129091","url":null,"abstract":"Natural medicine, although it has been used for centuries, has only recently gained increasing interest and is treated as a remedy for all ailments. It is very often abused due to a lack of sufficient knowledge about potential adverse reactions and possible interactions between plant preparations and particular drugs. Moreover, traditional medicine used for a long period of time without restriction can lead to permanent damage to health and even death. This paper outlines the dangers of harmful effects of plant preparations when used inappropriately and when co-interacting substances are combined.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70482097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AMA Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):210-219. doi:10.5114/pja.2023.131708. APA Harvanová, G., Duranková, S., & Bernasovská, J. (2023). The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology, 10(3), 210-219. https://doi.org/10.5114/pja.2023.131708 Chicago Harvanová, Gabriela, Silvia Duranková, and Jarmila Bernasovská. 2023. "The role of cytokines and chemokines in the inflammatory response". Alergologia Polska - Polish Journal of Allergology 10 (3): 210-219. doi:10.5114/pja.2023.131708. Harvard Harvanová, G., Duranková, S., and Bernasovská, J. (2023). The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.210-219. https://doi.org/10.5114/pja.2023.131708 MLA Harvanová, Gabriela et al. "The role of cytokines and chemokines in the inflammatory response." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 210-219. doi:10.5114/pja.2023.131708. Vancouver Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):210-219. doi:10.5114/pja.2023.131708.
AMA Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response.Alergologia Polska - Polish Journal of Allergology.2023;10(3):210-219. doi:10.5114/pja.2023.131708.APA Harvanová, G., Duranková, S., & Bernasovská, J. (2023).细胞因子和趋化因子在炎症反应中的作用》。https://doi.org/10.5114/pja.2023.131708 Chicago Harvanová, Gabriela, Silvia Duranková, and Jarmila Bernasovská.2023."细胞因子和趋化因子在炎症反应中的作用》。Alergologia Polska - Polish Journal of Allergology 10 (3)：210-219. doi:10.5114/pja.2023.131708.Harvard Harvanová, G., Duranková, S., and Bernasovská, J. (2023).细胞因子和趋化因子在炎症反应中的作用》。https://doi.org/10.5114/pja.2023.131708 MLA Harvanová, Gabriela et al. "The role of cytokines and chemokines in the inflammatory response." Alergologia Polska - Polish Journal of Allergology, 10(3), pp.210-219.Alergologia Polska - Polish Journal of Allergology, vol. 10, no.3，2023，pp.210-219.doi:10.5114/pja.2023.131708。Vancouver Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response.Alergologia Polska - Polish Journal of Allergology.2023;10(3):210-219. doi:10.5114/pja.2023.131708.
{"title":"The role of cytokines and chemokines in the inflammatory response","authors":"Gabriela Harvanová, Silvia Duranková, Jarmila Bernasovská","doi":"10.5114/pja.2023.131708","DOIUrl":"https://doi.org/10.5114/pja.2023.131708","url":null,"abstract":"AMA Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):210-219. doi:10.5114/pja.2023.131708. APA Harvanová, G., Duranková, S., & Bernasovská, J. (2023). The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology, 10(3), 210-219. https://doi.org/10.5114/pja.2023.131708 Chicago Harvanová, Gabriela, Silvia Duranková, and Jarmila Bernasovská. 2023. \"The role of cytokines and chemokines in the inflammatory response\". Alergologia Polska - Polish Journal of Allergology 10 (3): 210-219. doi:10.5114/pja.2023.131708. Harvard Harvanová, G., Duranková, S., and Bernasovská, J. (2023). The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.210-219. https://doi.org/10.5114/pja.2023.131708 MLA Harvanová, Gabriela et al. \"The role of cytokines and chemokines in the inflammatory response.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 210-219. doi:10.5114/pja.2023.131708. Vancouver Harvanová G, Duranková S, Bernasovská J. The role of cytokines and chemokines in the inflammatory response. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):210-219. doi:10.5114/pja.2023.131708.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135908263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adam Górka, Paulina Natalia Kopa-Stojak, Rafał Pawliczak
AMA Górka A, Kopa-Stojak P, Pawliczak R. Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):187-198. doi:10.5114/pja.2023.131709. APA Górka, A., Kopa-Stojak, P., & Pawliczak, R. (2023). Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology, 10(3), 187-198. https://doi.org/10.5114/pja.2023.131709 Chicago Górka, Adam, Paulina Natalia Kopa-Stojak, and Rafał Pawliczak. 2023. "Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study". Alergologia Polska - Polish Journal of Allergology 10 (3): 187-198. doi:10.5114/pja.2023.131709. Harvard Górka, A., Kopa-Stojak, P., and Pawliczak, R. (2023). Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.187-198. https://doi.org/10.5114/pja.2023.131709 MLA Górka, Adam et al. "Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 187-198. doi:10.5114/pja.2023.131709. Vancouver Górka A, Kopa-Stojak P, Pawliczak R. Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):187-198. doi:10.5114/pja.2023.131709.
{"title":"Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study","authors":"Adam Górka, Paulina Natalia Kopa-Stojak, Rafał Pawliczak","doi":"10.5114/pja.2023.131709","DOIUrl":"https://doi.org/10.5114/pja.2023.131709","url":null,"abstract":"AMA Górka A, Kopa-Stojak P, Pawliczak R. Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):187-198. doi:10.5114/pja.2023.131709. APA Górka, A., Kopa-Stojak, P., & Pawliczak, R. (2023). Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology, 10(3), 187-198. https://doi.org/10.5114/pja.2023.131709 Chicago Górka, Adam, Paulina Natalia Kopa-Stojak, and Rafał Pawliczak. 2023. \"Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study\". Alergologia Polska - Polish Journal of Allergology 10 (3): 187-198. doi:10.5114/pja.2023.131709. Harvard Górka, A., Kopa-Stojak, P., and Pawliczak, R. (2023). Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.187-198. https://doi.org/10.5114/pja.2023.131709 MLA Górka, Adam et al. \"Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 187-198. doi:10.5114/pja.2023.131709. Vancouver Górka A, Kopa-Stojak P, Pawliczak R. Specific allergen immunotherapy – comparison between allergoids and allergen vaccines. A real-life study. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):187-198. doi:10.5114/pja.2023.131709.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135909159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Community-acquired pneumonia (CAP), defined as acute pulmonary parenchymal infection acquired outside the hospital, remains one of the most common causes of hospitalization and death, especially among people over 65 and those with impaired immunity. This is a serious problem due to aging societies in many countries and comorbidities. Despite the development of diagnostic methods, in half of the patients with CAP, the etiology cannot be determined, which emphasizes the importance of empirical treatment and the risk of increasing antibiotic resistance to available preparations. In recent years, new antibiotics have been approved for the treatment of CAP, which may significantly improve the possibilities of empirical treatment of CAP
{"title":"The effectiveness of new antibiotics in the treatment of community-acquired pneumonia","authors":"Nikodem Trzcina, Joanna Wieczfinska, R. Pawliczak","doi":"10.5114/pja.2023.129082","DOIUrl":"https://doi.org/10.5114/pja.2023.129082","url":null,"abstract":"Community-acquired pneumonia (CAP), defined as acute pulmonary parenchymal infection acquired outside the hospital, remains one of the most common causes of hospitalization and death, especially among people over 65 and those with impaired immunity. This is a serious problem due to aging societies in many countries and comorbidities. Despite the development of diagnostic methods, in half of the patients with CAP, the etiology cannot be determined, which emphasizes the importance of empirical treatment and the risk of increasing antibiotic resistance to available preparations. In recent years, new antibiotics have been approved for the treatment of CAP, which may significantly improve the possibilities of empirical treatment of CAP","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70481329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Przemysław Seweryn, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, Rafał Pawliczak
AMA Seweryn P, Emeryk A, Kupczyk M, et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710. APA Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., & Sztaba, G. et al. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), 189-201. https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, and Rafał Pawliczak. 2023. "Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?". Alergologia Polska - Polish Journal of Allergology 10 (3): 189-201. doi:10.5114/pja.2023.131710. Harvard Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., Sztaba, G., and Pawliczak, R. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.189-201. https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław et al. "Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 189-201. doi:10.5114/pja.2023.131710. Vancouver Seweryn P, Emeryk A, Kupczyk M, Gawlik R, Dębowski T, Sztaba G et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710.
{"title":"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?","authors":"Przemysław Seweryn, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, Rafał Pawliczak","doi":"10.5114/pja.2023.131710","DOIUrl":"https://doi.org/10.5114/pja.2023.131710","url":null,"abstract":"AMA Seweryn P, Emeryk A, Kupczyk M, et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710. APA Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., & Sztaba, G. et al. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), 189-201. https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, and Rafał Pawliczak. 2023. \"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?\". Alergologia Polska - Polish Journal of Allergology 10 (3): 189-201. doi:10.5114/pja.2023.131710. Harvard Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., Sztaba, G., and Pawliczak, R. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.189-201. https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław et al. \"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 189-201. doi:10.5114/pja.2023.131710. Vancouver Seweryn P, Emeryk A, Kupczyk M, Gawlik R, Dębowski T, Sztaba G et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135908520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Krzysztof Buczyłko, Anna Bartnicka, Jerzy Kruszewski, Katarzyna Plata-Nazar, Krzysztof Piwowarek, Maciej Kupczyk, Radosław Gawlik, Dariusz Lebensztejn, Zbigniew Bartuzi, Jan Mazela, Agnieszka Szlagatys-Sidorkiewicz
AMA Buczyłko K, Bartnicka A, Kruszewski J, et al. Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):141-151. doi:10.5114/pja.2023.131553. APA Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., & Kupczyk, M. et al. (2023). Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology, 10(3), 141-151. https://doi.org/10.5114/pja.2023.131553 Chicago Buczyłko, Krzysztof, Anna Bartnicka, Jerzy Kruszewski, Katarzyna Plata-Nazar, Krzysztof Piwowarek, Maciej Kupczyk, and Radosław Gawlik et al. 2023. "Guidelines for the diagnosis and management of histamine intolerance". Alergologia Polska - Polish Journal of Allergology 10 (3): 141-151. doi:10.5114/pja.2023.131553. Harvard Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., Kupczyk, M., Gawlik, R., Lebensztejn, D., Bartuzi, Z., Mazela, J., and Szlagatys-Sidorkiewicz, A. (2023). Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.141-151. https://doi.org/10.5114/pja.2023.131553 MLA Buczyłko, Krzysztof et al. "Guidelines for the diagnosis and management of histamine intolerance." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 141-151. doi:10.5114/pja.2023.131553. Vancouver Buczyłko K, Bartnicka A, Kruszewski J, Plata-Nazar K, Piwowarek K, Kupczyk M et al. Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):141-151. doi:10.5114/pja.2023.131553.
AMA Buczyłko K, Bartnicka A, Kruszewski J, et al. 组胺不耐受的诊断和管理指南。Alergologia Polska - Polish Journal of Allergology.2023;10(3):141-151. doi:10.5114/pja.2023.131553.APA Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., & Kupczyk, M. et al. (2023)。组胺不耐受的诊断和管理指南》。https://doi.org/10.5114/pja.2023.131553 Chicago Buczyłko, Krzysztof, Anna Bartnicka, Jerzy Kruszewski, Katarzyna Plata-Nazar, Krzysztof Piwowarek, Maciej Kupczyk, and Radosław Gawlik et al. 2023."组胺不耐受的诊断和管理指南》。Alergologia Polska - Polish Journal of Allergology 10 (3)：141-151. doi:10.5114/pja.2023.131553.Harvard Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., Kupczyk, M., Gawlik, R., Lebensztejn, D., Bartuzi, Z., Mazela, J., and Szlagatys-Sidorkiewicz, A. (2023).组胺不耐受的诊断和管理指南》。https://doi.org/10.5114/pja.2023.131553 MLA Buczyłko, Krzysztof et al. "Guidelines for the diagnosis and management of histamine intolerance." Alergologia Polska - Polish Journal of Allergology, 10(3), pp.141-151.Alergologia Polska - Polish Journal of Allergology, vol. 10, no.doi:10.5114/pja.2023.131553.Vancouver Buczyłko K, Bartnicka A, Kruszewski J, Plata-Nazar K, Piwowarek K, Kupczyk M et al. 组胺不耐受的诊断和管理指南。Alergologia Polska - Polish Journal of Allergology.2023;10(3):141-151. doi:10.5114/pja.2023.131553.
{"title":"Guidelines for the diagnosis and management of histamine intolerance","authors":"Krzysztof Buczyłko, Anna Bartnicka, Jerzy Kruszewski, Katarzyna Plata-Nazar, Krzysztof Piwowarek, Maciej Kupczyk, Radosław Gawlik, Dariusz Lebensztejn, Zbigniew Bartuzi, Jan Mazela, Agnieszka Szlagatys-Sidorkiewicz","doi":"10.5114/pja.2023.131553","DOIUrl":"https://doi.org/10.5114/pja.2023.131553","url":null,"abstract":"AMA Buczyłko K, Bartnicka A, Kruszewski J, et al. Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):141-151. doi:10.5114/pja.2023.131553. APA Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., & Kupczyk, M. et al. (2023). Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology, 10(3), 141-151. https://doi.org/10.5114/pja.2023.131553 Chicago Buczyłko, Krzysztof, Anna Bartnicka, Jerzy Kruszewski, Katarzyna Plata-Nazar, Krzysztof Piwowarek, Maciej Kupczyk, and Radosław Gawlik et al. 2023. \"Guidelines for the diagnosis and management of histamine intolerance\". Alergologia Polska - Polish Journal of Allergology 10 (3): 141-151. doi:10.5114/pja.2023.131553. Harvard Buczyłko, K., Bartnicka, A., Kruszewski, J., Plata-Nazar, K., Piwowarek, K., Kupczyk, M., Gawlik, R., Lebensztejn, D., Bartuzi, Z., Mazela, J., and Szlagatys-Sidorkiewicz, A. (2023). Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.141-151. https://doi.org/10.5114/pja.2023.131553 MLA Buczyłko, Krzysztof et al. \"Guidelines for the diagnosis and management of histamine intolerance.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 141-151. doi:10.5114/pja.2023.131553. Vancouver Buczyłko K, Bartnicka A, Kruszewski J, Plata-Nazar K, Piwowarek K, Kupczyk M et al. Guidelines for the diagnosis and management of histamine intolerance. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):141-151. doi:10.5114/pja.2023.131553.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135908711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AMA Olgaç M, Demir S, Ünal D, et al. Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):180-186. doi:10.5114/pja.2023.131707. APA Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., & Büyüköztürk, S. et al. (2023). Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology, 10(3), 180-186. https://doi.org/10.5114/pja.2023.131707 Chicago Olgaç, Müge, Semra Demir, Derya Ünal, Raif Coşkun, Bahaauddin Çolakoğlu, Suna Büyüköztürk, and Aslı Gelincik. 2023. "Role of premedication to prevent reactions in cluster immunotherapy". Alergologia Polska - Polish Journal of Allergology 10 (3): 180-186. doi:10.5114/pja.2023.131707. Harvard Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., Büyüköztürk, S., and Gelincik, A. (2023). Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.180-186. https://doi.org/10.5114/pja.2023.131707 MLA Olgaç, Müge et al. "Role of premedication to prevent reactions in cluster immunotherapy." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 180-186. doi:10.5114/pja.2023.131707. Vancouver Olgaç M, Demir S, Ünal D, Coşkun R, Çolakoğlu B, Büyüköztürk S et al. Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):180-186. doi:10.5114/pja.2023.131707.
AMA Olgaç M, Demir S, Ünal D, et al.Alergologia Polska - Polish Journal of Allergology.2023;10(3):180-186. doi:10.5114/pja.2023.131707.APA Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., & Büyüköztürk, S. et al. (2023)。用药前预防集束免疫疗法反应的作用》（Role of premedication to prevent reactions in cluster immunotherapy）。https://doi.org/10.5114/pja.2023.131707 Chicago Olgaç, Müge, Semra Demir, Derya Ünal, Raif Coşkun, Bahaauddin Çolakoğlu, Suna Büyüköztürk, and Aslı Gelincik.2023."集束免疫疗法中预用药在预防反应中的作用》。Alergologia Polska - Polish Journal of Allergology 10 (3)：180-186. doi:10.5114/pja.2023.131707.Harvard Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., Büyüköztürk, S., and Gelincik, A. (2023).用药前预防集束免疫疗法反应的作用》（Role of premedication to prevent reactions in cluster immunotherapy.https://doi.org/10.5114/pja.2023.131707 MLA Olgaç, Müge et al. "Role of premedication to prevent reactions in cluster immunotherapy." Alergologia Polska - Polish Journal of Allergology, 10(3), pp.180-186.Alergologia Polska - Polish Journal of Allergology, vol. 10, no.doi:10.5114/pja.2023.131707.Vancouver Olgaç M, Demir S, Ünal D, Coşkun R, Çolakoğlu B, Büyüköztürk S et al.Alergologia Polska - Polish Journal of Allergology.2023;10(3):180-186. doi:10.5114/pja.2023.131707.
{"title":"Role of premedication to prevent reactions in cluster immunotherapy","authors":"Müge Olgaç, Semra Demir, Derya Ünal, Raif Coşkun, Bahaauddin Çolakoğlu, Suna Büyüköztürk, Aslı Gelincik","doi":"10.5114/pja.2023.131707","DOIUrl":"https://doi.org/10.5114/pja.2023.131707","url":null,"abstract":"AMA Olgaç M, Demir S, Ünal D, et al. Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):180-186. doi:10.5114/pja.2023.131707. APA Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., & Büyüköztürk, S. et al. (2023). Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology, 10(3), 180-186. https://doi.org/10.5114/pja.2023.131707 Chicago Olgaç, Müge, Semra Demir, Derya Ünal, Raif Coşkun, Bahaauddin Çolakoğlu, Suna Büyüköztürk, and Aslı Gelincik. 2023. \"Role of premedication to prevent reactions in cluster immunotherapy\". Alergologia Polska - Polish Journal of Allergology 10 (3): 180-186. doi:10.5114/pja.2023.131707. Harvard Olgaç, M., Demir, S., Ünal, D., Coşkun, R., Çolakoğlu, B., Büyüköztürk, S., and Gelincik, A. (2023). Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.180-186. https://doi.org/10.5114/pja.2023.131707 MLA Olgaç, Müge et al. \"Role of premedication to prevent reactions in cluster immunotherapy.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 180-186. doi:10.5114/pja.2023.131707. Vancouver Olgaç M, Demir S, Ünal D, Coşkun R, Çolakoğlu B, Büyüköztürk S et al. Role of premedication to prevent reactions in cluster immunotherapy. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):180-186. doi:10.5114/pja.2023.131707.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135908896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marta Latek, P. Lacwik, K. Molińska, A. Błauż, B. Rychlik, Dominik Strapagiel, J. Majak, Dorota Czech, P. Kuna, P. Majak
Introduction: The microbiome has been identified as a significant factor in the pathogenesis of various inflammatory and autoimmune diseases, including chronic rhinosinusitis (CRS), a condition that affects up to 12% of the global population. Aim: To evaluate the role of innate lymphoid cells (ILC1, ILC2, and ILC3) and their relationship with nasal microbiota in CRS in children. Material and methods: We assessed the clinical, microbiological, and immunological characteristics of 63 children with CRS. We evaluated disease severity using the Sinus and Nasal Quality of Life Survey (SN-5) and measured ILC1, ILC2, and ILC3 levels in nasal scrapings; microbial diversity was expressed as OTU richness. Results: We found a statistically significant relationship between ILC1 levels and CRS severity, suggesting a potential role of ILC1 in the development of the disease. ILC3 levels were significantly associated with lower microbial richness. While atopy was more common in children with high levels of ILC2, the relationship was not significant. Conclusions: Our results indicate that innate lymphoid cells may play a significant role in the inflammatory processes underlying the development and severity of chronic rhinosinusitis, with ILC1 activation being particularly strongly associated with CRS severity in young children. Additionally, ILC3 may play a role in modulating the nasal microbiome in CRS patients, but the relationship is not strong enough to significantly impact the clinical characteristics.
{"title":"The role of innate lymphoid cells in chronic rhinosinusitis\u0000severity in children: a cross-sectional study","authors":"Marta Latek, P. Lacwik, K. Molińska, A. Błauż, B. Rychlik, Dominik Strapagiel, J. Majak, Dorota Czech, P. Kuna, P. Majak","doi":"10.5114/pja.2023.129090","DOIUrl":"https://doi.org/10.5114/pja.2023.129090","url":null,"abstract":"Introduction: The microbiome has been identified as a significant factor in the pathogenesis of various inflammatory and autoimmune diseases, including chronic rhinosinusitis (CRS), a condition that affects up to 12% of the global population. Aim: To evaluate the role of innate lymphoid cells (ILC1, ILC2, and ILC3) and their relationship with nasal microbiota in CRS in children. Material and methods: We assessed the clinical, microbiological, and immunological characteristics of 63 children with CRS. We evaluated disease severity using the Sinus and Nasal Quality of Life Survey (SN-5) and measured ILC1, ILC2, and ILC3 levels in nasal scrapings; microbial diversity was expressed as OTU richness. Results: We found a statistically significant relationship between ILC1 levels and CRS severity, suggesting a potential role of ILC1 in the development of the disease. ILC3 levels were significantly associated with lower microbial richness. While atopy was more common in children with high levels of ILC2, the relationship was not significant. Conclusions: Our results indicate that innate lymphoid cells may play a significant role in the inflammatory processes underlying the development and severity of chronic rhinosinusitis, with ILC1 activation being particularly strongly associated with CRS severity in young children. Additionally, ILC3 may play a role in modulating the nasal microbiome in CRS patients, but the relationship is not strong enough to significantly impact the clinical characteristics.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70482079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：